Turinabol – Tbol – Doctor’s Analysis of Side Effects & Properties

Member Access Required

Join Now

Already a member? Sign In

Timeline

00:00

Historical development and misuse of Turinabol in state-sponsored doping programs.

04:20

Chemical structure, pharmacology, and anabolic properties of Turinabol.

08:40

Endocrine suppression and sex hormone binding globulin effects.

13:00

Liver toxicity, cardiovascular risks, and long-term safety concerns.

Video Summary

Turinabol was developed during the Cold War as part of a state-sponsored doping program. It was designed specifically to enhance athletic performance while minimizing visible side effects. The drug was never intended for widespread medical use. Its history includes administration to young athletes without informed consent. This legacy highlights ethical and medical failures. Understanding its origins helps contextualize its risks. History provides critical safety lessons.

Pharmacologically, Turinabol is a modified testosterone derivative. Its structure reduces aromatization but does not eliminate androgenic activity. The drug lowers sex hormone binding globulin, temporarily increasing free testosterone. Endogenous testosterone production becomes suppressed over time. This suppression leads to hypogonadism after discontinuation. Transient benefits do not offset long-term hormonal consequences. Endocrine recovery is unpredictable.

Serious adverse effects are emphasized in the final discussion. As a 17-alpha alkylated steroid, Turinabol is hepatotoxic. Cases of liver failure have been documented. Cardiovascular risks include severe HDL suppression and vascular damage. Hypertension and cardiac hypertrophy may develop. Using Turinabol with other steroids compounds risk. Caution and education are essential.

Drug Callouts

Turinabol

Turinabol is an oral anabolic steroid derived from testosterone with modifications reducing aromatization. It is discussed in the context of performance enhancement, endocrine suppression, and long-term toxicity.

Condition Callouts

Anabolic steroid induced hypogonadism

Anabolic steroid induced hypogonadism is suppression of the hypothalamic-pituitary-gonadal axis due to exogenous steroid exposure. The video explains how Turinabol contributes to long-term testosterone suppression.

Hepatotoxicity

Hepatotoxicity refers to liver damage caused by chemical substances including oral anabolic steroids. The video highlights severe liver injury risks associated with prolonged Turinabol use.

Key Takeaways

Turinabol was developed specifically for athletic doping and not for legitimate or ethical medical therapeutic use.
Despite low aromatization properties, Turinabol can still cause profound endocrine suppression and long-term hypogonadism.
Oral anabolic steroids like Turinabol significantly lower HDL cholesterol and increase cardiovascular disease risk.
Liver toxicity remains a serious danger due to 17-alpha alkylation and prolonged oral steroid exposure.
Perceived mildness does not equate to safety when anabolic steroids are used repeatedly or chronically.